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Abstract
Group B Streptococcus (GBS), a common commensal of the female genital tract, is the leading cause of invasive infections in
neonates. Expression of major GBS virulence factors, such as the hemolysin operon cyl, is regulated directly at the
transcriptional level by the CovSR two-component system. Using a random genetic approach, we identified a multi-
spanning transmembrane protein, Abx1, essential for the production of the GBS hemolysin. Despite its similarity to
eukaryotic CaaX proteases, the Abx1 function is not involved in a post-translational modification of the GBS hemolysin.
Instead, we demonstrate that Abx1 regulates transcription of several virulence genes, including those comprising the
hemolysin operon, by a CovSR-dependent mechanism. By combining genetic analyses, transcriptome profiling, and site-
directed mutagenesis, we showed that Abx1 is a regulator of the histidine kinase CovS. Overexpression of Abx1 is sufficient
to activate virulence gene expression through CovS, overcoming the need for an additional signal. Conversely, the absence
of Abx1 has the opposite effect on virulence gene expression consistent with CovS locked in a kinase-competent state.
Using a bacterial two-hybrid system, direct interaction between Abx1 and CovS was mapped specifically to CovS domains
involved in signal processing. We demonstrate that the CovSR two-component system is the core of a signaling pathway
integrating the regulation of CovS by Abx1 in addition to the regulation of CovR by the serine/threonine kinase Stk1. In
conclusion, our study reports a regulatory function for Abx1, a member of a large protein family with a characteristic Abi-
domain, which forms a signaling complex with the histidine kinase CovS in GBS.
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Introduction
Some commensal microorganisms are also opportunistic path-
ogens. Harmless, and potentially beneficial, they may become
causative agents of local or systemic infections [1,2]. To date, the
signals dictating the switch from commensalism to virulence are
mainly unknown. The complex set of genetic and environmental
factors thought to be involved would affect the equilibrium
between the host and the microbes. Deciphering the molecular
events that govern the transition between commensalism and
virulence will contribute to understanding and controlling
infections due to opportunistic pathogens.
Streptococcus agalactiae (Group B Streptococcus, GBS) is a commensal
bacterium of the adult gastro-intestinal tract and is present
asymptomatically in the vaginal flora of 10–30% of healthy
women [3]. However, GBS is the leading cause of invasive
infections in neonates (pneumonia, septicaemia, and meningitis)
and a serious cause of mortality or morbidity in adults with
underlying diseases [4–6]. As with most streptococci, the ability of
GBS to cause infections is multifactorial [7]. The main virulence-
associated GBS proteins identified to date are secreted or surface
components, including the ß-hemolysin/cytolysin and specific
adhesins [7–10].
Expression of several major GBS virulence genes is regulated at
the transcriptional level by a two-component system (TCS) called
CovSR (Control of virulence Sensor and Regulator; also known as
CsrSR) [10–13]. TCS is the main signaling mechanism used by
bacteria to respond to their changing environments [14]. CovSR
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controls the GBS response to acid stress in vitro and is necessary in
vivo at several steps of the infectious process, such as resistance to
macrophage killing and penetration of the blood-brain barrier
[15–18]. Depending on the model of infection, inactivation of the
CovSR system leads to a decrease or an increase of virulence [11–
13,15], suggesting that this system is tightly regulated in space and
time to specifically adapt the bacterial virulence capacities to the
infected compartments of the host. CovSR orthologs are present in
several streptococcal species, including Streptococcus pyogenes (Group
A Streptococcus, GAS), where their function as a master regulator
of virulence gene expression is conserved [19–23].
The CovSR system belongs to the EnvZ/OmpR family of TCS,
where CovS is the membrane-bound histidine protein kinase (HK)
and CovR is the cytosolic response regulator (RR). Typically, HK
is the sensor of an environmental stimulus that induces its
autophosphorylation and, subsequently, phosphorylation of its
cognate RR [14]. Phosphorylation of the RR alters its function,
generally by modifying its binding affinity for target promoter
regions and thereby changing expression of specific genes or
operons. In contrast to the majority of TCS, the streptococcal
CovSR regulatory pathway is a combination of two antagonistic
negative regulators [24]. Indeed, in both GBS and GAS, the
phosphorylated CovR acts mainly as a transcriptional inhibitor by
direct binding to target gene promoters [11,13,25–27]. It was
therefore suggested, but not formally demonstrated in vitro, that
CovS acts mainly as a phosphatase on CovR to de-repress
virulence gene expression during infection [13,24,28]. Currently, it
is not known whether CovS is activated by general stresses [16,28]
and/or is a direct sensor of specific ligands [22]. The latter
hypothesis is supported in GAS by the identification of extracel-
lular Mg2+ and sub-inhibitory concentrations of LL-37, an
antimicrobial peptide secreted by innate immune cells, as specific
ligands that respectively activate and inhibit CovS activity
[22,29,30].
Additional levels of TCS regulation exist that do not depend
directly on environmental signal sensing by the HK sensor [31–
33]. These cellular regulators target either the HK or the RR and
were named ‘‘third components’’, ‘‘auxiliary proteins’’, ‘‘adaptors’’
or ‘‘TCS connectors’’. While keeping the specific molecular links
between an HK and its cognate RR, the additional cellular
regulator allows to coordinate the cellular response and/or to
integrate multiple signals [33]. This is the case in GBS where
CovR activity is modulated by a second signaling pathway
mediated by the serine/threonine kinase Stk1 [15,25,34]. Direct
phosphorylation of the CovR T65 threonyl residue by Stk1
decreases CovR activity and interferes negatively with CovS-
dependent phosphorylation of the D53 aspartyl residue [25]. These
CovS- and Stk1- signaling pathways converge on CovR and are
both necessary for GBS virulence [15].
In this study, we identified and characterized a transmembrane
protein, Abx1, belonging to a large family of bacterial proteins of
unknown function that have a conserved domain called Abi
[35,36]. We provide evidence that the putative protease activity of
Abx1, inferred from its similarity to eukaryotic CaaX proteases
[35,36], is not necessary for its function. Instead, we demonstrate
that Abx1 is an additional partner of the CovSR system that is
necessary to regulate CovS activity by a protein-protein interac-
tion. We show that the Abx1-CovS signaling complex and the
Stk1-dependent pathway are both necessary to control CovR
activity. In addition to defining the genetic network controlling
virulence gene expression in GBS, we provide the first report of a
cellular regulator of HK activity belonging to the large family of
bacterial Abi-domain proteins.
Results
Gbs1532/Abx1 is required for pigment production and
hemolysis in GBS
The ß-hemolysin/cytolysin expressed by GBS is an important
virulence factor encoded within a cluster of twelve genes forming
the cyl operon [8,37,38]. Hemolytic activity of GBS is always
associated with the synthesis of an orange pigment. Among the 12
genes of the cyl operon (gbs0644-gbs0655 genes), the CylE protein
(gbs0651) is the critical determinant for the dual hemolytic/
pigmentation phenotypes [8,38–40]. Inactivation of cylE abolishes
hemolytic activity and pigmentation, and the mutant is less
virulent in animal models of systemic infections [39–41].
Screening of a collection of random Himar1 insertional mutants
derived from the NEM316 wild-type (WT) strain allowed us to
identify mutants that mapped in the cyl operon [40]. We extended
this approach with approx. 2,500 new Himar1 mutants screened
for hemolytic activity on blood agar plates and for pigmentation
on Granada agar, a specific medium that stabilizes the GBS
pigment [42]. We focused our analysis on four mutants displaying
a strong decrease in pigmentation and hemolytic activity on
Granada and Blood agar plates (see Figure 1A for two of these four
phenotypically identical mutants). The four mutants have unique
and independent Himar1 insertions in the uncharacterized gene
gbs1532 as revealed by direct sequencing on chromosomal DNAs.
This 921-bp gene encodes a 306 amino acid protein annotated as
a hypothetical protein or putative protease (NCBI ref. seq.
NP_735969). Transposon insertions of the four Himar1 mutants
were in positions 85, 347, 625, and 632 in the DNA coding
sequence, leading to truncated proteins at codons 29, 116, 209,
and 211, respectively.
Blast similarity searches, domain analyses, and topology
prediction (Figure S1) revealed that Gbs1532 belongs to a
conserved superfamily of putative membrane-bound metallopro-
teases related to eukaryotic CaaX proteases [35,36]. The
characteristic domain of this superfamily of more than 5,500
proteins is the Abi-domain (Pfam02517). To our knowledge, none
Author Summary
The gram-positive Streptococcus genus includes three
major human pathogens that are members of the normal
microflora: Streptococcus pneumoniae (also known as the
pneumococcus), Streptococcus pyogenes (Group A Strepto-
coccus), and Streptococcus agalactiae (Group B Streptococ-
cus). Their carriage in the population is highly dynamic and
mostly asymptomatic. However, each of these species can
cause a wide spectrum of diseases, from local infections to
systemic and fatal infections including septicemia and
meningitis. Expression of streptococcal virulence-associat-
ed genes is tightly regulated at the transcriptional level.
However, the signal(s) and the precise molecular events
controlling the switch from commensalism to virulence are
not yet understood. In this study, we identified and
characterized a bacterial protein essential for virulence
gene expression in Group B Streptococcus, the main
pathogen of neonates. We show that this transmembrane
protein, named Abx1, interacts with the histidine kinase
CovS to modulate the activity of the major regulator of
virulence CovR. We define how a core set of four proteins,
Abx1, CovS, CovR, and the serine/threonine kinase Stk1,
interact to control the expression of virulence genes in S.
agalactiae. We propose that Abx1-like proteins, that are
widespread in bacteria, might be part of a conserved
mechanism of two-component system regulation.
Genetic Architecture of the CovSR Network in GBS
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of the bacterial Abi-domain proteins are functionally characterized
to date [36]. We therefore named the translated gbs1532 gene
product Abx1, for Abi-domain protein related to CaaX protease,
and renamed the corresponding gene accordingly (i.e., abx1). This
abx1 gene belongs to the core genome of all sequenced GBS strains
[43,44] and 6 other genes coding for Abi-domain proteins similar
to Abx1 are present in their genomes (Figure S1).
To confirm that abx1 is required for pigmentation and
hemolysis, we constructed in-frame deletion mutant (Dabx1) in
the NEM316 WT strain. The Dabx1 mutant displayed the same
phenotypes as the Himar1 mutants (Figure 1B). Furthermore,
pigment production and hemolysis were restored upon ectopic
expression of abx1 transcribed from its own promoter (Figure 1A
and 1B: pTCVVabx1 complementing vector) confirming that abx1
was responsible for the observed phenotypes.
Overexpression of Abx1 increases hemolysis and
pigment production
Wild-type or Dabx1 mutant strains expressing Abx1 from the
complementing plasmid pTCVVabx1were more pigmented and more
hemolytic than the control strains (Figure 1B). This suggests that the
expression level of Abx1 might be limiting for pigment production and
hemolysis. To test this hypothesis, we cloned abx1 downstream of two
constitutive promoters with different strength (Ptet and Pcyl+) to generate
the overexpressing vectors pTCVVPtet_abx1, and pTCVVPcyl+_abx1,
respectively. Furthermore, we engineered the WT strain to replace the
chromosomal Pabx1 promoter by the Pcyl+ promoter (DPabx1::Pcyl+). All
recombinant strains carrying the different overexpression forms of abx1
displayed hyper-hemolysis on blood agar and hyper-pigmentation on
Granada agar (Figure 1C). Determination of the hemolytic titer of the
different mutants and quantification of the corresponding abx1
transcription levels further confirmed the link between hemolysis and
abx1 expression (Table 1). Remarkably, the pigmentation level also
correlated with the strength of the abx1 upstream promoter
(Ptet.Pcyl+.Pabx1) on TH agar, a medium where pigmentation is
usually not observed (Figure 1C). Overexpression of Gbs1037, the
closest Abx1 homolog in GBS (40% identity over 222 residues, E-
value=e-11; Figure S1) and of the unrelated EFGP (Enhanced Green
Fluorescence Protein) did not modify pigmentation and hemolysis of
NEM316, underlining the specific activity of Abx1 (Figure 1C). The
activity of Abx1 is a conserved feature within the GBS species since
abx1 deletion or overexpression in several clinical strains (serotypes Ia,
515; Ib, H36B; II, 18RS21; III, BM110; and V, 2603V/R; [44]) has a
strong effect on their hemolytic activities and pigmentation (Figure S2).
Induction of hemolysis by Abx1 is not achieved by
prenylation- or protease-activity
In eukaryotes, Abi-domain-containing proteins (Pfam02517) are
CaaX prenyl proteases involved in protein prenylation
[35,36,45,46]. These transmembrane proteases remove the
Figure 1. The Abx1 (Gbs1532) protein is essential for hemolytic activity and pigment production in GBS. (A) ß-hemolytic and
pigmentation phenotypes of NEM316 wild-type strain (WT) and of two independent insertional mutants (abx1::Him1 and abx1::Him2) obtained by
random transposon mutagenesis. Strains contained the empty vector pTCV or the complementing vector pTCVVabx1 where abx1 is transcribed from
its own promoter. Pigment production was assayed on Granada agar plates and hemolytic activities on Columbia horse blood (5%) agar plates. The
clear halos surrounding bacterial colonies (black dots) on blood plates correspond to lysed erythrocytes. Plates are supplemented with erythromycin
(10 mg/ml) for plasmid maintenance. (B) Phenotypes of in-frame abx1 deletion mutant (Dabx1). Strains contained the same vectors as in (A).
Overnight cultures in TH were diluted in fresh media and approximately 103 and 102 CFU were spotted on TH, Granada, and Columbia horse blood
agar plates plus erythromycin. Pictures were taken after 24–36 h of growth at 37uC. (C) Hemolytic and pigmentation phenotypes associated with
abx1 overexpression. WT strain with the empty vector pTCV, the complementing vector pTCVVabx1, the overexpressing vectors pTCVVPcyl+_abx1 or
pTCVVPtet_abx1, the negative control vectors pTCVVPcyl+_gbs1037 or pTCVVPcyl+_EGFP were spotted onto TH, Granada, and blood agar plates
containing erythromycin. An overexpression mutant where the abx1 chromosomal promoter was replaced by the strong Pcyl+ promoter (DPabx1::Pcyl+)
was similarly spotted on agar plates without antibiotic. TH and Granada plates were photographed after 24–36 h of growth, while blood agar plates
were photographed after 16 h of growth at 37uC.
doi:10.1371/journal.ppat.1003179.g001
Genetic Architecture of the CovSR Network in GBS
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carboxy-terminal aaX tripeptide of a protein after the addition of
an isoprenyl group on the cysteyl residue of the CaaX motif. One
of the main features of the Abi-domain is the presence of four
predicted core transmembrane helical segments (labeled TMH1–
4) containing conserved active-site residues (Figure S1D). The
overall topology and the critical residues for protease activity are
conserved in Abx1 (Figure 2A and S1). To date, prenylation was
never described in prokaryotic cells but, intriguingly, the CylE
hemolysin contains a cysteyl residue at the fourth position from its
carboxylic end (i.e., the critical residue of the CaaX motif [46]).
We tested whether CylE could be post-translationally modified
by a prenylation-like mechanism involving Abx1. Overexpression
of Abx1 using pTCVVPcyl+_abx1 in the non-hemolytic and non-
pigmented DcylE mutant did not increase hemolysis or pigmen-
tation (Figure 2B), confirming that Abx1 function is strictly
dependent on the presence of a functional CylE. We then
substituted the cysteyl residue of CylE located at the fourth
position from its carboxy-terminal end by an alanyl (CylE C664A).
This mutation did not alter pigmentation and hemolysis signifi-
cantly (Figure 2B), which suggests that CylE is not prenylated on
this cysteyl, and consequently that Abx1 might not be a CaaX
protease. To further test whether Abx1 has protease activity, we
replaced the conserved residues (glutamyl at positions 164 and 165
and histidyl at positions 197 and 235) described as critical for this
enzymatic activity by alanyl residues (Figure 2A; [47]). All alleles
obtained for Abx1 (E164A, E165A, EE164/165AA, H197A, H235A)
restored hemolysis and pigment production when expressed in a
Dabx1 mutant strain (Figure 2C). Hence, the putative protease
activity of Abx1 is not necessary for the CylE dependent
phenotypes.
Abx1 and CovR, the major regulator of virulence gene
expression, are functionally linked
Abx1 activity is dependent of CylE but appears to be
independent of a CylE post-translational modification. To
decipher the relationship between Abx1 and cyl-dependent
hemolysis and pigment production, we took advantage of the
previously described DCBSCyl mutant where the CovR binding
sites (CBS) in the promoter of the cyl operon were deleted [40].
Since CovR acts as a transcriptional repressor of the cyl operon,
deletion of CBSCyl leads to strong constitutive expression of the cyl
operon. Consequently, the DCBSCyl mutant is hyperhemolytic and
hyperpigmented in all tested conditions (Figure 3A). Whereas abx1
deletion in a WT background abolishes pigmentation and
hemolysis, deletion of abx1 in a DCBSCyl background
(Dabx1DCBSCyl) did not affect the hyper-hemolytic and hyper-
pigmented phenotypes of the parental DCBSCyl strain (Figure 3A).
This result suggests that Abx1 acts upstream of CovR-mediated
transcriptional inhibition of the cyl operon.
To confirm this epistatic interaction, we inactivated covR
(gbs1672) and the complete covSR two-component system
(gbs1671–1672) in the WT and Dabx1 backgrounds. As expected,
inactivation of covR or covSR in the WT strain led to hyper-
pigmentation and hyper-hemolysis (Figure 3A). Similarly, inacti-
vation of CovR or CovSR in the Dabx1 background restored
pigmentation and hemolysis to levels similar to those observed in
the DcovR and DcovSR mutants (Figure 3A). This suggests that
Abx1 is an inhibitor of CovR activity. Consistently, Western blot
analysis of the adhesin BibA and CAMP factor whose expression
are negatively and positively regulated by CovR [11,13],
respectively, revealed similar expression patterns in the DcovR
and abx1 overexpression mutants: inactivation of CovR or
overexpression of abx1 dramatically increased BibA production
and abolished secretion of the CAMP factor (Figure 3B). These
results demonstrate that Abx1 activity is not restricted to
Table 1. Hemolytic titer is dependent of abx1 expression
level.
Strain Hemolytic titer abx1 expression*
WT+pTCV 1 1.0 (+/20.1)
WT+pTCVVabx1 4–8 2.4 (+/20.2)
WT+pTCVVPcyl+_abx1 16–32 13.2 (+/21.3)
WT+pTCVVPtet_abx1 32 24.3 (+/24.9)
WT+pTCVVPcyl+_gbs1037 0.5–1 n.d.
WT 1 1.0 (+/20.1)
DPabx1::Pcyl+ 16–32 4.0 (+/20.5)
*As measured by qRT-PCR and reported as expression ratio against the WT
strain. Mean +/2 SD of three independent experiments. n.d. = not determined.
doi:10.1371/journal.ppat.1003179.t001
Figure 2. Abx1 function is dependent of the CylE ß-hemolysin
through a protease-independent activity. (A) Abx1 is a member of
a large family of proteins related to eukaryotic CaaX proteases [35,36].
The three most conserved motifs of the Abi-domain (Pfam02517) are
depicted for Abx1 and Gbs1037 from S. agalactiae, Spr1119 from S.
pneumoniae, SagE from S. pyogenes and for two eukaryotic CaaX
proteases, the budding yeast ScRCE1 and the human HsBRCA2.
Conserved amino acids essential for CaaX protease activity are in red
with the putative catalytic glutamic acid (E) residue shown by a plus (+).
Figure S1 provides additional information on the Abi-domain family. (B)
The CylE hemolysin is essential for Abx1 function on hemolysis and
pigmentation. GBS hemolysis and pigmentation were observed on TH,
Granada (Gr) and Blood agar (Bl). Strains are: (a) in-frame cylE deletion
mutant (DcylE) with the empty vector pTCV or the abx1 overexpression
vector pTCVVPcyl+_abx1; and (b) WT, abx1 deletion mutant (Dabx1) and
a mutant with a cysteyl to alanyl substitution in the CaaX motif of CylE
(CylE C664A), i.e., the putative prenylation site of CylE. (C) Conserved
amino acids critical for CaaX protease activity are not required for Abx1
activity. The non-hemolytic and apigmented Dabx1 mutant were
complemented with pTCVVabx1 vectors encoding a wild-type allele
(Abx1) or several alanine substitution alleles in the predicted critical
glutamic acid (E) or histidine (H) residues.
doi:10.1371/journal.ppat.1003179.g002
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pigmentation and hemolysin production, and suggest an antago-
nist function on CovR activity.
Abx1 inhibits CovSR signaling by antagonizing CovS
To decipher the relationship between Abx1 and the CovSR
two-component system, we compared the transcriptomes of DcovS,
DcovR and DcovSR mutants with the Dabx1 deletion mutant and
two abx1 overexpression mutants (v_Oe_abx1=vector based abx1
overexpression with the pTCVVPcyl+_abx1 plasmid; and
K_Oe_abx1=chromosomal abx1 overexpressing strainDPabx1::Pcyl+).
Pairwise comparisons of Log2 expression ratios (Table S1, N=1,905
genes) revealed highly similar expression changes between the strain
carrying the chromosomal overexpression of abx1 (K_Oe_abx1) and
the DcovS and DcovR deletion mutants (Figure 4A: Pearson
correlation=0.704 and 0.727, respectively). Strikingly, the transcrip-
tome profiles of the abx1 overexpression and DcovS deletion mutants
form a distinct cluster as revealed by hierarchical clustering analysis
(Figure 4B and S3A).
Detailed analyses revealed a cluster of genes containing the
direct and conserved targets that are negatively regulated by CovR
(Figure 4C and S3B: N= 29 and 40 genes with expression change
log2.2 and .1 in at least one strain, respectively). Expression of
nearly all of these genes, including the cyl operon (gbs0644–
gbs0655) and the bibA gene (gbs2018), were dependent on the
expression level of abx1. Moderate overexpression of abx1 in the
chromosome (DPabx1::Pcyl+; 3.7 fold change by microarrays)
induced a transcriptome response highly similar to that of the
DcovS mutant (Figure 4C). Greater overexpression of abx1
(pTCVVPcyl+_abx1; 9.1 fold change by microarrays) further
increased expression of the direct-CovR regulated gene set to a
level close to that observed in a DcovR mutant (Figure 4C). In
contrast, downregulation below the significant threshold is
observed in the Dabx1 mutant (Figure 4C). qRT-PCR analysis
on a set of 6 genes regulated by the CovSR system confirmed gene
expression changes identified by microarray analysis (Figure 4D).
Moreover, bibA and CAMP factor transcription levels in the DcovR
deletion and abx1 overexpression mutants are in accordance with
the corresponding protein expression levels as observed by
Western analysis (Figure 3B). Taken together, the similarities
between abx1 overexpression mutants and cov deletion mutants
suggest that Abx1 exerts a specific effect on the CovSR two-
component system, most likely by acting as a CovS antagonist.
Abx1 interacts directly with the histidine kinase CovS
Our results suggest an inhibitory function of Abx1 on CovS
activity or that Abx1 protects or sequesters CovR, impeding its
phosphorylation by CovS either directly or indirectly. To
discriminate between these possibilities, we used a bacterial two-
hybrid system [48] to test the physical interactions of Abx1 with
different putative partners. This showed that Abx1 is able to form
homodimers and that it interacts indeed with CovS but not with
CovR (Figure 5A and 5B). The Abx1-CovS interaction is specific,
as Abx1 did not interact with two other GBS HKs that are similar
to CovS (Figure 5A: Gbs2082 and Gbs0430). To define the regions
involved in the Abx1-CovS interaction, we tested the interaction of
Abx1 with different domains of CovS (Figure 5C). These
experiments showed that Abx1 interacts specifically with the
amino-terminal part of CovS containing its extracytoplasmic and
transmembrane domains (Figure 5D). Deletion of the extracyto-
plasmic loop of CovS did not impede interaction with Abx1,
suggesting that the loop is not directly required for Abx1-CovS
interaction (Figure 5D: CovS form VI). No interaction was
detected either with the carboxy-terminal part of CovS containing
the catalytic domains or with CovS truncated forms containing
only one transmembrane domain (Figure 5D). These results
suggest that Abx1 interacts with the two CovS transmembrane
domains involved in signal processing.
Abx1 function is dependent on CovS histidine kinase/
phosphatase activities
In agreement with the proposed inhibitory function of Abx1 on
CovS, deletion of covS in a Dabx1 background (Dabx1DcovS) restores
pigment production and hemolysis of the non-pigmented and non-
hemolytic Dabx1 mutant to levels similar to those of the DcovS
mutant (Figure 6A). However, as seen previously by transcriptome
analysis, the DcovS mutant is not identical to the DcovR mutant. In
particular, the DcovR mutant is hyper-pigmented and hyper-
hemolytic (see Figure 3A) while the DcovS mutant is only slightly
affected in pigmentation and hemolysis compared to the WT
strain (Figure 6A).
To explain these observations, we must consider the three
common activities of histidine kinases (HK): auto-phosphorylation
of the kinase on a histidyl residue, phospho-transfer on an aspartyl
residue of the cognate regulator, and phosphatase activity of the
HK on its cognate regulator [14]. Deletion of covS abolishes the
Figure 3. The two-component system CovSR is epistatic to Abx1. (A) Control of hemolysin and pigment production by Abx1 is dependent on
the two-component system CovSR. Phenotypic comparison of WT and abx1 mutant without or with mutations in CovR (DcovR), CovSR (DcovSR), and
in the CovR binding sites of the cyl operon (DCBScyl), as assayed on TH, Granada (Gr) and Blood agar (Bl) plates. (B) CovR-regulated genes are similarly
expressed in abx1-overexpressing and covR-deletion mutants. Immunoblots of the surface-exposed adhesin BibA (Gbs2018) and secreted CAMP
factor (Gbs2000) in cell wall extracts and concentrated supernatants, respectively. The Bsp protein was used as a loading control. Specificities of BibA
and CAMP factor antibodies were confirmed with extracts from deletion mutants of the corresponding genes (negative controls).
doi:10.1371/journal.ppat.1003179.g003
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Figure 4. Abx1 inhibits the CovSR system. Transcriptome analysis of deletion (Dabx1, DcovS, DcovR, and DcovRS) and overexpressing (Oe_abx1)
mutants. The latter mutants were obtained either by chromosomal replacement of the abx1 WT promoter by the strong constitutive promoter Pcyl+
(K_Oe_abx1) or by using the overexpression vector pTCVVPcyl+_abx1 (v_Oe_abx1). The WT strain with the empty vector (NEM_ery) was included to
take into account the potential effect of erythromycin (10 mg/ml) used to maintain the abx1 overexpression vector. (A) Pairwise comparisons of Log2
expression ratios for 1,905 genes between abx1 overexpressing mutant (K_Oe_abx1) and DcovR (blue dots) or DcovS (red dots) deletion mutants.
Pearson’s correlations (r2) were calculated to estimate similarities in gene expression change. (B) Heatmap of the genes (N= 147) with an absolute
log2 ratio .2 in at least one strain. Gene expression changes were color-coded (blue =down; yellow=up). Hierarchical clustering (uncentered;
average linkage) was done for genes (upper tree) and strains (right tree). Genes of the CovSR regulon conserved in 3 sequenced GBS strains (NEM316,
A909, and 2603V/R) are highlighted below the heatmap (blue line = down-conserved; yellow line =up-conserved). (C) Highlight of the gene cluster in
(B) containing the conserved negatively regulated genes of the CovSR regulon (in dark red letters). The gene tree is shown on the left of the heatmap
and the corresponding gene identifiers and protein annotations are indicated on the right. Genes marked with a star were selected for confirmation
of gene expression by qRT-PCR. Enlarge version of (B) and (C) heatmaps at a lower threshold ( = absolute log2 ratio .1 in at least one strain) are
presented in supplementary figure S3. (D) qRT-PCR expression analysis of selected genes in abx and cov mutants. The relative expression level of
abx1, of 5 negatively-regulated CovR genes (cylE, cylJ, bibA, gbs0791 and gbs1037), and of one positively-regulated CovR gene (cfb coding the CAMP
factor) were measured in Dabx1, DcovS, and DcovR deletion mutants, in the WT and Dabx1 mutant containing the abx1 complementing vector (+
abx1; plasmid pTCVVabx1), and in two abx1 overexpressing mutants (K_Oe_abx1= chromosomal abx1 overexpression; v_Oe_abx1= vector-based
abx1 overexpression with the pTCVVPcyl+_abx1 plasmid). Results are the relative expression level between mutant and WT strains expressed as the
means value (+/2 SEM) from three independent cultures in triplicates.
doi:10.1371/journal.ppat.1003179.g004
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three activities. In this case, cross-phosphorylation of the regulator
by small metabolites or by a non-cognate HK can be observed due
to the absence of the phosphatase activity of the cognate HK
[49,50]. Thus, in the DcovS mutant, cross-phosphorylation of
CovR might enable its partial activation. To gain experimental
evidence, we constructed CovS and CovR alanyl substitution
mutants in conserved residues critical for each of the three
activities associated with HK [14]. First, we targeted the phospho-
acceptor histidyl residue H278 to obtain an auto-phosphorylation
deficient allele of CovS. Second, we replaced the aspartyl residue
D53 of CovR normally phosphorylated by CovS to abolish
phospho-transfer between CovS and CovR [25,26]. Third, we
replaced the CovS threonyl residue T282 that was proposed to be
specifically involved in HK phosphatase activity [50,51]. We then
used pigmentation and hemolysis production as reporters of
CovSR activity (Figure 6B).
The CovR D53A mutant displayed a hyper-hemolytic and
hyper-pigmented phenotype like the DcovR mutant (Figure 6B), as
also observed previously in another GBS strain [25], supporting
the model of CovR as a transcriptional repressor under its D53
P
phosphorylated form. Analyses of the CovS H278A mutant strain
showed phenotypes similar to the DcovS mutant (Figure 6B),
suggesting that the H278 residue is essential for all three activities,
as assumed by a mechanistic model of HK activity [50,51]. We
identified in CovS the conserved threonyl residues specifically
required for the phosphatase reaction of several HK [50,51].
Interestingly, the CovS T282A mutant is non-hemolytic and non-
pigmented (Figure 6B) indicating that CovR is locked in an active
form that fully inhibits the expression of the cyl operon.
Overexpression of abx1 in the DcovS, CovS H278A or CovS
T282A mutants did not modify their phenotypes, indicating that
Abx1 activity is dependent on CovS kinase/phosphatase activities
(Figure 6C). The fact that overexpression of abx1 in the WT
context led to hyper-pigmented and hyper-hemolytic phenotypes,
as seen for the DcovR and CovR D53A mutants (Figure 6), suggests
that Abx1 actively stimulates CovS-dependent dephosphorylation
of CovR. Expression level measurements of selected CovR-
regulated genes (cylE, cylJ, bibA, gbs0791, gbs1037, and cfb coding
the CAMP factor) in CovS and CovR alanyl substitution mutants
confirm that the broad effect of abx1 overexpression depends upon
a functional CovS histidine kinase (Figure 6D). Overall, our results
support a model where Abx1 inhibits the kinase-competent form
and/or stabilizes the phosphatase-competent form of CovS.
Abx1-CovS and Stk1 converge to regulate CovR activity
An additional regulator of the CovSR system is the eukaryotic-
like serine/threonine kinase Stk1. It has been shown in vitro that
Stk1 regulates CovR negatively by direct phosphorylation of the
Figure 5. Abx1 physically interacts with the HK CovS. The physical interactions between proteins were assayed using a two-hybrid system in E.
coli. Fusion proteins were constructed with the T18 or the T25 adenylate cyclase fragments. The activity of the ß-galactosidase cAMP-dependent
reporter gene, expressed in arbitrary units (AU), was determined as described in Materials and Methods. Means and standard deviations are
calculated from at least three independent cultures. (A) Interactions between Abx1 and the transcriptional regulator CovR, the histidine kinase CovS,
and two others GBS histidine kinase (Gbs2082 and Gbs0430). The T18 and the T25 tags are located at the C-terminal end of tested proteins.
Interactions of Abx1-T18 (dark blue) were measured against the indicated T25 tag protein. Reciprocally, interactions of Abx1-T25 (light blue) were
measured against the indicated T18 tag protein. (B) Homo-dimerizations were measured by the interaction between the T18 and T25 fusions of the
same proteins and are show with light grey bars. The specific interaction between the HK CovS and its RR CovR is shown with dark grey bars. (C)
Schematic representation of the CovS histidine kinase domains and of the truncated alleles used in (D). The amino-terminal part of CovS (residues 1–
211) is made of two transmembrane (TM) domains flanking an extracellular loop. The cytoplasmic carboxy-terminal part of CovS (residues 211–501)
contains the typical HAMP, HisKA and HATP regulatory and catalytic domains. Truncated alleles (I to VI) were tag with either T18 or T25 at the C-
terminal end (I to III) or at the N-terminal end (IV to VI). A full length CovS allele tagged at the N-terminal end (VII) was added as a control. (D)
Interactions between Abx1 and truncated alleles of CovS. The CovS alleles with a C-terminal tag were tested against the corresponding Abx1 tagged
at its C-terminal end (blue). Similarly, the CovS alleles with a N-terminal tag were tested against the corresponding Abx1 tagged at its N-terminal end
(red).
doi:10.1371/journal.ppat.1003179.g005
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threonyl residue at position 65 (T65) [25,34]. The CovR T65
phosphorylation by Stk1 has been proposed to be mutually
exclusive of CovR D53 phosphorylation by CovS [25]. Consis-
tently, the Dstk1 (Dgbs0307) mutant is strongly and negatively
affected in pigment production and hemolytic activity (Figure 7),
in agreement with an inhibitory role of Stk1 on CovR activity.
To learn whether Abx1 and Stk1 function together, we tested if
Abx1 and Stk1 interact using the bacterial two-hybrid system. No
interaction was observed (data not shown). Furthermore, pigmen-
tation and hemolysis were restored in the non-pigmented and non-
hemolytic Dstk1 strain upon increasing abx1 copy number with
plasmid pTCVVabx1 (Figure 7). This indicates that Abx1 is able to
bypass CovR activation observed in the absence of Stk1. However,
pigmentation and hemolysis levels of the Dstk1 strain carrying the
pTCVVabx1 vector are below those of the WT strain (Figure 7).
This result suggests that abx1 overexpression needs a functional
Stk1 to fully inhibit CovR activity.
Finally, a condition-dependent toxicity was observed when the
overexpressing pTCVVPcyl+_abx1 vector was introduced into theDstk1
mutant. Specifically, strong overexpression of abx1 in Dstk1 is toxic on
Granada agar (Figure 7). This phenotype is CovS-dependent as toxicity
is alleviated in a Dstk1DcovS double mutant, which is unresponsive to
abx1 overexpression (Figure 7). This result reinforces the link between
Abx1 and a functional CovS. In addition, the Dstk1DcovS mutant is
locked in an intermediate phenotype (Figure 7), revealing a partial
inhibition of CovR in the absence of CovS. Thus, CovS appears
necessary for complete activation of CovR in the absence of Stk1, most
likely by an active CovR D53 phosphorylation. As shown in the model
depicted Figure 8, we propose that the regulatory function of Abx1 is
absolutely dependent on CovS but also depends on the serine/
threonine kinase Stk1 to control CovR activity by a convergent
signaling pathway.
abx1 expression level is critical for virulence
The CovSR two-component system is a master regulator of GBS
virulence gene expression. In order to assess the role of Abx1 in GBS
virulence, neonatal rat pups were infected by intraperitoneal injection
of 56106 bacteria of either the Dabx1 deletion or abx1 overexpressing
mutants. In this model, both mutants exhibited reduced virulence
compared to the parental WT strain (Figure 9). It is noteworthy that
the abx1 overexpression mutant is totally avirulent (100% survival) and
that neonates did not display any sign of illness during the course of two
independent experiments (data not shown). These results show that
abx1 expression at an appropriate level is required to develop GBS
infection.
Discussion
The CovSR two-component system (TCS) is the major
regulator of virulence gene expression in GBS. In this study, we
Figure 6. CovS activities are Abx1-dependent. (A) CovS is epistatic to Abx1. Phenotypes of the WT strain, Dabx1, Dabx1DcovS, and DcovS
deletion mutants. (B) CovS kinase/phosphatase activities are essential for CovR regulation. Phenotypes of DcovS deletion mutant were compared with
those of critical point mutants of CovS (H278A and T282A) or CovR (D53A). The histidine residue number 278 (H278) is the conserved phospho-accepting
residue essential for the autophosphorylation of CovS. The threonine number 282 (T282) is a conserved residue necessary for the phosphatase activity
of several HKs. The aspartate number 53 (D53) is the conserved residue of CovR phosphorylated by CovS. (C) Abx1 is dependent of CovS activities.
Phenotypes of WT, DcovS, and CovS H278A or CovS T282A alanine substitution mutants overexpressing abx1 (+Pcyl+_abx1=plasmid pTCVVPcyl+_abx1).
The hyper-pigmentation and hyper-hemolysis associated to abx1 over-expression in WT strain are suppressed in DcovS and CovS H278A mutants.
Reversion of CovS H278A and T282A substitution back to the WT CovS sequence (indicated by _WT) restores the abx1 over-expression associated-
phenotypes. All assays were performed on TH, Granada (Gr) and blood agar (BI) plates. (D) abx1 overexpression effects are dependent of CovS
enzymatic activities. Relative expression levels of selected genes were measured by qRT-PCR in logarithmic growing cells in TH media. Relative
expression levels of abx1, of five negatively regulated CovR genes (cylE, cylJ, bibA, gbs0791 and gbs1037), and of one positively regulated CovR gene
(cfb coding the CAMP factor) were measured in CovS and CovR alanyl substitution mutant, and in WT and CovS alanyl substitution mutants
overexpressing abx1 (+Pcyl+_abx1=plasmid pTCVVPcyl+_abx1). Results are means +/2 sem from three independent cultures in triplicates.
doi:10.1371/journal.ppat.1003179.g006
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identified the Abx1 transmembrane protein as essential and
limiting for CovSR activity due to its interaction with the CovS
histidine kinase (HK). Regulation of HK activity by an interacting
protein is increasingly recognized when studying TCS signaling in
a cellular context [31–33]. Instead of being a linear signaling
pathway, our data show that the CovSR TCS is embedded in a
regulatory network involving several regulatory proteins, including
the Abi-domain protein Abx1.
Abx1 as a histidine kinase regulator
We first observed that Abx1 is required for hemolysin and
pigment production in GBS and that abx1 overexpression in a WT
background increases hemolysin and pigment production in a
dose-dependent manner. These abx1 effects depend upon a
functional CovSR pathway, which directly controls expression of
the cyl operon. In agreement with a regulatory activity of Abx1 on
the CovSR system, modulation of abx1 expression affected not
only hemolysin/pigment production but also production of the
adhesin BibA and the CAMP factor, two direct targets of CovR
[11,13]. Indeed, genome-wide transcriptome profiling suggested a
specific and antagonistic activity of Abx1 on the CovSR system.
By combining genetic analysis and protein-protein interactions,
we show that Abx1 acts through the HK CovS to control the
activity of CovR. The transmembrane protein CovS is the cognate
HK of CovR. However, in contrast to the majority of TCS, CovR
is mainly a transcriptional inhibitor when phosphorylated on the
conserved D53 residue and CovS is assumed to be primarily a
phosphatase necessary to relieve repression of virulence genes
during infection [11–13,24]. Our data support this regulatory logic
(i.e., the inactivation by CovS of the CovR inhibitor) but show in
addition that Abx1 exerts a cellular control on the dual kinase/
phosphatase activity of CovS (Figure 8). By using the cyl operon as
reporter of CovR activity, we observed constitutive CovR
activation with a CovS allele (CovS T282A) mutated in the
conserved threonyl residue specifically involved in the phosphatase
activity of several other HKs [50,51] or by deletion of Abx1
(Figure 8B). Conversely, CovR can be inactivated by a D53A
substitution, mimicking a non-phosphorylated allele, or by
overexpression of Abx1 (Figure 8C). Furthermore, all of these
Abx1 effects are dependent on a functional CovS. Taken together,
these results suggest that the level of Abx1 is critical to control the
equilibrium between the kinase and phosphatase activities of
CovS.
It is noteworthy that inactivation of both CovS kinase and
phosphatase activities, either with a CovS H278A allele or by
deleting covS, led to intermediate phenotypes compared to those
obtained by CovR inactivation. This pattern has been observed
previously in GBS [13] and GAS for the CovSR ortholog
[24,52,53]. In this condition, it is likely that CovR is partially
activated by cross-phosphorylation, either by small metabolites like
acetyl-phosphate or by a non-cognate HK. The specific phospha-
tase activity of CovS avoids inappropriate activation of CovR by
other pathways, a general mechanism to insulate TCS signaling
pathways [49].
Importantly, HK phosphatase activity is not simply the reverse
reaction of the kinase activity [50,51]. The two activities involve
different, but potentially overlapping, catalytic residues [50] and
are mutually exclusive since they depend on different conforma-
tions of HK homodimers [14]. Both Abx1 and CovS are
transmembrane proteins. We found that Abx1 interacts directly
with CovS input domains (i.e., the extracellular and transmem-
brane domain), and ompacts CovS output domains (i.e., the
catalytic cytoplasmic domain). Current models of HK activity
regulation are based on different conformational states of HK
homodimers [14]. It is therefore most likely that Abx1 interferes
with the dynamic process of CovS conformational changes
propagated along the whole proteins to control the kinase/
phosphatase switch [14]. In the absence of Abx1, CovS appears to
be locked into a kinase-competent conformation while overex-
pression of Abx1 will result in stabilization of the phosphatase-
competent conformation (or destabilization of the kinase-compe-
tent form). Of note, the CovS extracellular loop is not necessary
for the physical interaction with Abx1 and it is therefore likely that
the main domains of CovS interacting with Abx1 are the
transmembrane domains flanking this loop. These HK trans-
membrane domains control the conformational rotation of the
cytoplasmic subunits of HK homodimer by a rotation or a piston
mechanism [54,55]. Thus, intra- and inter-molecular interactions
Figure 7. CovR-dependent phenotypes are regulated by
convergent signaling pathways mediated by Abx1-CovS and
Stk1. Phenotypes associated to the inactivation of the serine/threonine
kinase Stk1 in a WT background (Dstk1) and in combination with CovS
inactivation (Dstk1DcovS). All strains were transformed with the empty
vector pTCV or derivatives. To complement the Dstk1 mutant, the two-
gene operon containing stk1 was cloned with its promoter into the
pTCV vector (pTCVVstp-stk). To compare the effect of Abx1 on CovR-
dependent phenotypes, the Abx1 complementing vector (pTCVVabx1)
or the Abx1 over-expression vector (pTCVVPcyl+_abx1) were introduced
into relevant strains. Increased pigmentation and hemolysis due to the
presence of the abx1 vectors are indicated with a plus sign (+), absence
of effect of the abx1 vectors are indicated by a minus sign (2), and
condition-dependent toxicity of abx1 overexpression specifically on
Granada medium is indicated by a mark (#). All assays were performed
on TH, Granada (Gr) and blood agar (BI) plates.
doi:10.1371/journal.ppat.1003179.g007
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interfering with this dynamic process will impact the catalytic
activity by blocking HKs in a kinase or a phosphatase form
[56,57].
Positive and negative regulation of HK activity by physical
interactions with transmembrane regulators has been described in
both gram-negative and gram-positive bacteria [31,32]. Members
of this category are mainly small hydrophobic peptides, like the
PhoQ-B1500/SafA [58], PhoQ-MgrB [59] and EnvZ-MzrA [60]
pairs in enteric bacteria, or proteins with a single transmembrane
domain, like the YycH and YycI proteins regulating the essential
HK YyfG in Bacillus subtilis [61,62]. In particular, structural
modeling suggests that the YyfG HK is inactivated by its
interactions with YyfH and YyfI in the membrane environment
[62]. In analogy, this suggests a mechanism of CovS inactivation
by its interaction with the eight predicted transmembrane
spanning domains of Abx1 (Figure S1).
Figure 8. Proposed model of virulence gene regulation by the CovS/Abx1/Stk1/CovR network. (A) Simplified wiring diagram of the
regulatory network controlling GBS hemolysin and pigment production. In a WT context, the Abi-domain protein Abx1 maintains the equilibrium
between the kinase (green arrow) and the phosphatase activity (red lines) of the HK CovS. Activation of the RR CovR by CovS-dependent
phosphorylation increases its inhibitory activity on cyl operon transcription. Inhibition of CovR is dependent on its dephosphorylation by CovS and its
phosphorylation by the Stk1 serine/threonine kinase. In this condition, the cyl operon is expressed at a level defining the WT b-hemolytic and
pigmentation phenotype. (B) In the absence of Abx1, the HK CovS is locked in its kinase-competent form that activates CovR, thus inhibiting the
expression of the cyl operon. Phosphorylation of CovR by CovS precludes the Stk1-dependent CovR phosphorylation, leading to minimal CovR
inhibition by Stk1. In this condition, GBS are non-hemolytic and non-pigmented. (C) In the presence of an excess of Abx1, the kinase-competent form
of CovS is inhibited and/or the phosphatase-competent form is stabilized. The kinase Stk1 is necessary to fully inactive CovR, thereby allowing a
strong expression of the cyl operon. In this condition, GBS are hyper-hemolytic and hyper-pigmented. (D) An integrated model for CovSR signaling
with modular schematization of CovS (blue), Abx1 (green), Stk1 (red) and CovR (purple). The CovR activity reflects the equilibrium between the
mutually exclusive ATP-dependent phosphorylation of two critical residues: threonyl 65 (T65) by Stk1 and aspartyl 53 (D53) by CovS, as proposed in
[15,25]. This equilibrium is dependent on Abx1, which is essential for CovS-dependent inactivation of CovR (red arrow). Modulation of CovR affinities
for DNA by phosphorylation regulates the expression of target genes, among which those necessary for stress resistance, host adhesion and damages
characteristic of invasive bacterial forms. Potential connections on the core of the signaling network are in grey (other Stk1 targets, putative Stp
phosphatase activity, putative interaction of CovS-Abx1 with other HKs, putative CovR phosphorylation by small phosphate donor as acetyl-
phosphate).
doi:10.1371/journal.ppat.1003179.g008
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The CovS-Abx1 signaling module
Abx1 controls GBS virulence gene expression by regulating
CovS activity, via a mechanism independent of the direct sensing
of an environmental signal by CovS. This cellular regulation of
TCS by a ‘‘third’’ component raises the question of how this
additional regulator is itself regulated [32,33]. The HK regulator
may set up a feedback loop when located in the same operon as
the HK, as for B. subtilis YycHI [61,62], or it may act as a TCS
connector when its transcription is controlled directly by another
TCS [31] as for E. coli B1500/SafA, MgrB, and MzrA peptides
mentioned above [58–60]. We did not find evidence that abx1
transcription is directly controlled by CovR (data not shown) but
cannot exclude transcriptional regulation by an as yet unidentified
RR.
An alternative hypothesis would be an allosteric regulation and/
or a scaffolding function of Abx1 [33]. Regulation of HK activity
by signal(s) not directly recognized by the HK but sensed and/or
transmitted by its interactor(s) might be a common mechanism, as
already described for antimicrobial cationic peptide resistance
modules in Firmicutes [63,64] and for HK-HK complex formation
in Pseudomonas aeruginosa [65]. Until now, it is not known how CovS
activity is regulated in GBS. In GAS, the CovS ortholog
(displaying 50.3% identity with the GBS CovS) is thought to be
a direct sensor of magnesium and of the human antimicrobial
peptide LL-37 [22,29,30]. However, only two Abi-domain
proteins are present in GAS genomes and neither is an Abx1
ortholog (Figure S1). Although the biological function of the CovS
orthologs in virulence is conserved [19,20], GAS and GBS inhabit
different ecological niches (nasopharynx and skin for GAS; gut and
vagina for GBS), suggesting a species-specific response by CovS.
The identification of conditions bypassing the Abx1 effects in GBS
will be valuable for characterizing the putative signal(s) directly
sensed by CovS.
We found that activity of the Abx1-CovS module depends upon
a second signaling pathway mediated by the serine/threonine
kinase Stk1 [25,34]. The two pathways converge on CovR to
regulate virulence gene expression (Figure 8). In vitro, direct
phosphorylation of the CovR T65 threonyl residue by Stk1
interferes negatively with phosphorylation of the conserved D53
aspartyl residue and decreases CovR affinity for its target
promoters [25,34]. By genetic analysis, we found that the Abx1-
CovS and the Stk1 signaling pathways are dependent on each
other to fulfill complete activation or inhibition of CovR. CovR
phosphorylation on T65 and D53 are mutually exclusive [25],
strongly suggesting that CovR has three possible states (Figure 8D:
D53
P T65 = active; D53 T65 = inactive I dephosphorylated; D53
T65
P = inactive II). It should be noted that Stk1 has additional
direct targets beyond CovR and that its activity depends upon its
associated phosphatase Stp1 [66–69]. Interestingly, a Dstk1mutant
is affected in cell cycle progression ([66] and data not shown), as
observed in S. pneumoniae and other bacteria [70,71], and Stk1
might respond to the release of cell wall components into the
extracellular environment by growing bacteria [72]. Therefore, it
appears that CovR integrates at least two types of signals to
coordinate virulence gene expression (via Abx1-CovS) with the
control of bacterial division (through Stk1).
This integrated system might be necessary to accurately control
GBS lifestyle from commensalism to invasive infection [15]. The
attenuated virulence of both deletion and overexpression abx1
mutants supports this dynamic view of the infectious process. The
survival of animals challenged intraperitoneally with the overex-
pressing abx1 mutant is reminiscent of the decreased virulence of
DcovR mutants previously described [11–13]. Several virulence
genes controlled by CovR are involved at several steps of the
infectious process, ranging from stress resistance to adherence to
host cell [10,11,13,16,18,73]. Among the genes directly regulated
by CovR, the hemolysin/cytotoxin CylE has key functions [39]. At
sub-lytic concentrations, CylE induces an anti-inflammatory
response [74], while high CylE expression induces a pro-
inflammatory response [41]. The inappropriate activation of a
strong pro-inflammatory response during initial steps of the
infectious process might explain, at least in part, the loss of
virulence of mutants overexpressing abx1 or inactivated for covR. In
contrario, at a latter stage of infection, these mutants can be more
virulent due to the cytotoxic effect of CylE on blood cells, as seen
with a DcovR mutant injected intravenously in mice [15]. Overall,
these results indicate that the Abx1-CovS-CovR-Stk1 regulatory
network controls the fine-tuning of virulence gene expression
which is critical for GBS disease progression.
The bacterial Abi-domain protein family
The demonstration that Abx1 is a cellular regulator of CovS
represents a new function for a bacterial Abi-domain protein. The
Abi-domain (Pfam02517) of Abx1 is the characteristic domain of a
large transmembrane protein family (.5,000 sequences) with up
to 15 members per bacterial species [35,36]. This family is mostly
uncharacterized to date in prokaryotes but includes the eukaryotic
type II CaaX proteases involved in protein prenylation [36,45].
However, prenylation appears restricted to eukaryotes and the two
examples of prenylated bacterial proteins, SifA of Salmonella
typhimurium and AnkB of Legionella pneumophila, are bacterial
effectors modified by the eukaryotic enzymes after their injection
into the host cell [75–77]. Our characterization of targeted
mutations (Figure 2) did not sustain our initial hypothesis of a
prenylation-like modification of the CylE hemolysin. Moreover,
the putative catalytic residues inferred from similarities with CaaX
proteases are not necessary for Abx1 activity. Given the high
conservation of these residues (Figure S1), we cannot rule out that
Abx proteins have protease activity. However, the main function
of Abx1 as a regulator of the CovS histidine kinase does not
require this putative protease activity.. Strikingly, the absence of a
protease activity was already suggested for a Staphylococcus aureus
Abi-protein involved in lysostaphin resistance [78]. Interestingly,
three of the four S. aureus Abi-domain genes were identified
recently in a genome-wide screen for altered targeting of cell-
surface proteins [79]. These defects are mainly due to decreased
transcription of the corresponding genes in the absence of the Abi-
Figure 9. Virulence of abx1 mutants. Mortality curves in neonate
rats infected with the WT strain (black circle), the Dabx1 deletion
mutant (blue square), and the K_Oe_abx1 overexpressing mutant (red
triangle). Two days rat pups were inoculated by intraperitoneal
injection of 56106 bacteria. The results shown are the mean of two
independent experiments (2610 rats per group).
doi:10.1371/journal.ppat.1003179.g009
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domain proteins [79], suggesting a conserved mechanism in gene
transcriptional regulation.
Finally, it should be mentioned that about one-fifth (.1,000) of
bacterial Abi-domain proteins are annotated as ‘‘abortive infection
protein’’ due to a historical miss-annotation [36] leading to
confusion between Abi phenotypes [80] and Abi-domain proteins
[36]. It was also suggested that Abi proteins are involved in self-
immunity against bacteriocins [81]. However, only a small subset
of Abi-proteins (less than 1%) is localized in putative bacteriocin-
encoding loci [81] or in operons encoding small toxins [82,83]. In
particular, the gene encoding the Abi-domain protein, SagE is
located in the operon directing synthesis of the S. pyogenes ß-
hemolysin known as streptolysin S or SLS [8,84]. However,
genetic analysis of this locus did not provide any conclusive clues
about the SagE function [84–86]. Abi-domain proteins localized in
toxin operons remain to be experimentally characterized for their
involvement in toxin production and/or regulation.
Conclusions
Studies of TCS signaling in cellular context have identified a great
variety of additional TCS partners, targeting either the HK or the RR
[31,32]. In this study, we demonstrated that the Abi-domain protein
Abx1 is a regulator of the HK CovS in GBS. The CovSR system was
presumed to be a linear signaling pathway. We show here that the
CovSR TCS is the core of a signaling network and propose a new
regulatory model, depicted in Figure 8, which includes Abx1-dependent
CovS regulation and Stk1-dependent CovR regulation [25,34].
Deciphering the additional CovSR input/output associated with these
cellular regulators might prove useful for understanding the GBS
transition from commensalism to virulence. Strikingly, Abx1 belongs to a
very large family of multi-spanning transmembrane proteins that remain
mostly uncharacterized to date [35,36] and are highly conserved at the
species level. It is therefore tempting to extend our findings to other
members of this family. The characterization of other Abx-like proteins
in GBS (Figure S1) and in other bacteria will reveal whether they belong
to a functionally conserved family of HK regulators.
Materials and Methods
Ethics statement
Animal experiments were performed at the Institut Pasteur (Paris,
France) animal husbandries in accordance with the policies of the
European Union guidelines for the handling of laboratory animals
(http://ec.europa.eu/environment/chemicals/lab_animals/home_en.
htm) and were approved by the Institut Pasteur animal care and use
committee (Nu04.118).
Bacterial strains and growth conditions
The reference WT GBS strain used in this study is NEM316, a
ST-23 and serotype III clinical isolate responsible for a fatal case of
septicaemia, whose sequenced genome [43] is accessible (NCBI
RefSeq NC_004368.1). The relevant characteristics of the
bacterial strains and plasmids used in this study are summarized
in Table S2. GBS was cultured in Todd Hewitt (TH) broth (Difco
Laboratories) at 37uC without agitation. Escherichia coli DH5a
(Invitrogen) and XL1 Blue (Stratagene) were grown in Luriani
Broth (LB) medium. When specified, antibiotics were used at the
following concentrations: for E. coli: ticarcillin, 100 mg/ml;
erythromycin, 150 mg/ml; kanamycin, 25 mg/ml; for GBS:
erythromycin, 10 mg/ml; kanamycin, 1,000 mg/ml.
Characterization of pigmentation and hemolytic activity
Pigmentation and ß-hemolytic activity were detected on
Granada agar and Columbia agar supplemented with 5% horse
blood, respectively (BioMe´rieux, France). Overnight GBS cultures
in TH were washed, adjusted to 108 CFU/ml, serially diluted
(dilution factor 10) in microplates and spotted on appropriate agar
plates. Horse blood plates were incubated at 37uC for 16–24 h,
followed by an additional 16–24 h incubation at room tempera-
ture or 4uC depending on the hyper- or hypo-hemolytic mutants
being tested. To highlight the halo of lysis due to the ß-hemolysin,
photographic acquisitions of blood agar plates were taken with
light from below. Whole images were further converted to gray
scale and processed (Photoshop CS4, Adobe, US) to adjust
contrast and brightness. Granada plates were incubated 20–36 h
at 37uC in anaerobic condition (AnaeroGen, Oxoid, UK).
Photographic acquisitions of TH and Granada plates were done
with side lighting from above and whole images were processed for
contrast and brightness.
GBS hemolytic titers were determined by a semi-quantitative
method as described previously, with slight modifications [11].
Briefly, culture adjusted to 2.108 CFU/ml in Phosphate Buffer
Saline (PBS) solution supplemented with 0.2% glucose were
serially diluted (dilution factor = 2) in microplates. One volume
(100 ml) of 1% defibrinated horse blood (Oxoid, UK) in 0.2%
glucose PBS was added in each well and plates were incubated 1 h
at 37uC. After gentle centrifugation (5 min. at 1000 rpm) to pellet
unlysed cells, the amount of hemoglobin in 100 ml of supernatants
was quantified by optical absorbance at 420 nm. Hemolytic
activity of each strain was defined as the minimum dilution that
lysed at least 10% of red blood cells. Hemolytic titers were defined
by the ratio between hemolytic activities of each strain against the
hemolytic activity of the WT strain (titer X= activity X/activity
WT). Negative and positive controls were PBS ( = 0% lysed cells)
and 0.1% SDS ( = 100% lysed cells) instead of bacterial cells,
respectively. All assays were performed in triplicates with
independent cultures.
DNA manipulation and mutant construction
Purification of GBS genomic DNA and E. coli plasmids DNA
was done on columns following manufacturer instructions
(DNeasy Blood and Tissue kit and Quiaprep Spin Minipreps kit,
respectively, Qiagen). Oligonucleotides (MWG and Sigma) used in
this study are listed in Table S3. Analytical PCR used standard
Taq polymerase (Invitrogen, Life technologies) and preparative
PCR for cloning and sequencing was carried out with a high
fidelity polymerase (Phusion, Finnzymes). Sanger sequencing was
done at the Institut Pasteur sequencing core facility (Paris, France)
using the ABI PRISM 3.1 dye terminator cycle sequencing kit
(Applied Biosystems) or outsourced (Beckman Coulter Genomic,
UK).
Plasmids for overexpression and complementation (pTCV
backbone, Table S2), deletion (pG+host5 backbone, Table S2)
and for bacterial double hybrid (pUT18 and pKNT25 backbones,
Table S2) were constructed by standard cloning procedures and all
inserts were fully sequenced. Primer pairs, DNA matrix and
restriction enzymes used for each vector are detailed in Table S4.
For several constructs, we used a splicing by overlap-extension
method [87] to generate in-frame deletion cassettes, site-directed
mutagenesis inserts or translational fusions (Table S4). For
instance, deletion cassettes for chromosomal in-frame deletions
were generated by combining two 500 bp PCR products,
corresponding to genomic sequences flanking the region to be
deleted, that were designed to have 25–50 bp of homology with
each other at one end [87]. The 1 kb amplification products
obtained with external primers were subsequently cloned into the
thermosensitive shuttle plasmid pG+host5 backbone and se-
quenced (Table S4).
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Plasmids were introduced in GBS by electroporation. For
chromosomal gene inactivation/modification, allelic exchanges
were selected as described [88,89]. Deletions and site-directed
substitutions were confirmed by sequencing PCR products
obtained with primers designed outside the genomic region used
for the construction of the corresponding cassette (Table S3 and
S4).
Detection of cell wall and secreted proteins
Secreted proteins were purified from 40 ml TH broth cultures
collected at mid-exponential phase (DO600 nm= 0.5). Supernatants
were filter sterilized and concentrated 50-fold using Vivaspin 20
columns (Sartorius). Cell-wall proteins were prepared from
overnight cultures at 37uC in TH by mutanolysin (Sigma-Aldrich)
digestion in osmo-protective buffer as described [73,89]. Following
SDS-PAGE electrophoresis, proteins were transferred onto a
nitrocellulose membrane (GE Healthcare) and detected using
rabbit specific polyclonal antibodies [73] and horseradish perox-
idase (HRP)-coupled anti-rabbit secondary antibodies. Signals
were detected by chemiluminescence (ECL, GE Healthcare).
RNA isolation and analysis
Total RNAs were extracted from exponentially growing cells
(OD600 = 0.4–0.5) in TH at 37uC with a phenol/Trizol-based
purification method as previously described [11]. Reverse
transcription was done with Superscript indirect cDNA kit
(Invitrogen, Life technologies) and qPCR was carried out with
SYBR Green PCR kits (Applied Biosystems, Life technologies).
Relative quantification of specific gene expression was calculated
with the 22DDCt method, with gyrA as the housekeeping reference,
and normalized against the NEM316 wild-type. Each assay was
performed at least in triplicate on three independent cultures.
For microarray analysis, identical culture conditions and RNA
purification procedures were used. The three independent cDNA
preparations of each strain were labeled with Cy5 or Cy3
(Amersham Biosciences) for dye swap hybridizations against
NEM316 wild-type strain RNA prepared in parallel. The 15K
custom microarray (Agilent Technologies) contains 8,691 60-mer
oligonucleotides specific for the 2134 predicted genes and long
intergenic region of the NEM316 strain [90]. Arrays were scanned
in an Axon 4000B dual laser scanner and treated as described
[90]. Raw data have been submitted to the ArrayExpress database
under the Accession number E-MEXP-3703 (http://www.ebi.ac.
uk/arrayexpress/). Hierarchical clustering were done with Cluster
3.0 and visualized with Java TreeView.
Bacterial two-hybrid (BATCH) system
For BACTH assays [48], chimeric GBS proteins fused to either
T18 or T25 fragments of adenylate cyclase (CyaA) were
constructed by conventional cloning in pUT18 and pKNT25
vectors for T18/25 C-terminal tagging or in pUT18C and pKT25
for T18/25 N-terminal tagging (Table S2 and S4). Physical
interactions were assayed in E. coli DHT1 cells (Table S2) co-
transformed with recombinant pKNT25/pKT25 and pUT18/
pUT18C vectors. Interaction efficiencies between hybrid proteins
were quantified by measuring ß-galactosidase activity in 96-well
plates assays. Bacteria were grown overnight at 30uC in 1 ml LB
broth in the presence of 0.5 mM IPTG and appropriate antibiotics
in 2.2 ml 96-deepwell plates (Thermo Scientific). To permeabilize
cells, 100 ml of bacterial cultures in 96 deepwell polypropylene
plates were treated with 500 ml of buffer containing ß-mercapto-
ethanol (50 mM), SDS (0.2% v/v) and chloroform (3% v/v) and
vortex two times 1 min (Mixmate, Eppendorf). For the enzymatic
reaction, 40 ml of ONPG (4 mg/ml) was added to 120 ml of the
permeabilized cells solution in a new microplate. Reaction kinetics
at 28uC were followed by recording the OD420 every 4 min for
60–90 min in a microplate reader (Synergy, BioTek). Slopes
(min21) with a correlation coefficient r2$0.98 were used to
calculated enzymatic activities relative to internal negative (pUT18
and pKNT25 empty vectors; activity =O arbitrary units) and
positive controls (pUT18-zip and pKNT25-zip vectors, [48];
activity = 1,000 arbitrary units) incorporated in each microplate.
Slopes420 was divided by the OD600 of each culture to normalize
for initial cell density. At least four independent cultures were done
for each plasmid combination. All recombinant pKNT25/pKT25
and pUT18/pUT18C vectors were tested against the correspond-
ing empty vector and gave background level of ß-galactosidase
activity (not depicted in Figure 5).
In vivo virulence assay
Two-days old neonatal Sprague-Dawley rat pups (Janvier, Le
Genest Saint Isle, France) were used for mortality curve
experiments. Randomized groups of 10 neonatal rat pups were
infected by intraperitoneal (i.p.) injection with 56106 bacteria in
100 ml PBS. Survivals were monitored for five days after injection
and two independent experiments were carried out.
Supporting Information
Figure S1 Abx1 is a multi-spanning transmembrane
protein belonging to a large family related to CaaX
prenyl proteases. (A) Prediction of transmembrane domains in
the Abx1 sequence by the TMHMM v.2.0 software (Center for
Biological Sequence Analysis, Technical University of Denmark).
The eight predicted transmembrane domains with a probability
greater than 0.5 are illustrated above with red boxes. The four
transmembrane domains containing the conserved Abi-domain
signature are highlighted with a yellow box. (B) Identification of
Abi-domain proteins in the genome of S. agalactiae, S. pneumoniae,
and S. pyogenes. Proteins containing the Abi-domain (Pfam domain
PF02517, Wellcome Trust Sanger Institute, UK) were retrieved
from a representative genome of each species. Protein length, Abi-
domain start and end residues used for the alignment, and Abi-
domain score and probabilities are given for each protein of this
family. For comparaison, two eukaryotic CaaX proteases from S.
cerevisiae (ScRCE1) and H. sapiens (HsBRCA2) are included. (C)
Cladogram of selected streptococcal Abi-domain proteins. Multi-
ple alignments of full protein sequences and unrooted tree were
done with ClustalX 2.1 (University College Dublin, Ireland). Tree
branches with a bootstrap value above .0.9 (1,000 repetitions) are
indicated with a red diamond. The dark-red diamond represents a
bootstrap value above .0.9 when analysing only the Abi-domain
of each proteins as represent in (D). S. agalactiae, S. pneumoniae, and
S. pyogenes proteins are in blue, red and green letters, respectively.
(D) Multiple sequence alignments of streptococcal Abi-domain
adapted with the representation of Pei J., Grishin N.V. and co-
workers [35,36]. The conserved topology included the four
predicted transmembrane domains (TMH1 to TMH4) that are
mainly made of uncharged residues (yellow background) and each
containing a typical motif (motif 1 to motif 4). Highly conserved
residues of motifs 1 (EExxxR), 2 (FxxxH) and 4 (HxxxN) are
shown in white letters on a black background, while substitutions
at these sites are on gray background. Putative cation-binding
residues (1 glutamyl, E; 2 histidyl, H) and the predicted catalytic
site (1 glutamyl) are marked below the two eukaryotic CaaX
prenyl proteases with an asterisk and a plus sign, respectively. Seryl
(S) and threonyl (T) residues in THM2 are highlighted with a
green background. The more variable motif 3 (sxxxs, where
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s = small residues) is highlighted with a violet background. This
variable motif is useful to classify Abi-domain proteins when
related protein super-families (not depicted here) are considered
[36].
(TIF)
Figure S2 Conservation of the Abx1 function at the
species level. Deletion (A) and overexpression (B) of abx1 were
carried out in the WT strains BM110 (serotype III, ST17), 2603
V/R (serotype V, ST110), 515 (Serotype Ia, ST23), H36B
(Serotype Ib, ST6) and 18RS21 (Serotype II, ST19). The abx1
gene is conserved among the core genome of WT GBS isolates. It
is 100% identical in the NEM316, 2603 V/R, H36B, and 18RS21
genomes; and differs by 1 SNP in the 515 genome (resulting in one
amino acid change T107I); and by 5 SNPs in the BM110 genome
(all being silent mutation at the protein level). Deletion mutant
(Dabx1) and return to the abx1 WT allele (WTback) were selected
after chromosomal integration of the abx1 deletion vector in each
strain and the subsequent chromosomal excision of this vector. For
abx1 overexpression, each strain was transformed with the pTCV
empty vector and the pTCVVPcyl+_abx1 overexpressing vector
(abbreviated Pcyl+_abx1). Serial dilutions (10 fold factor) of cultures
were spotted on TH, Granada and Columbia supplemented with
5% horse blood agar plates. Erythromycine (10 mg/ml) was added
when necessary for plasmids maintenance. Plates were photo-
graphed after 16–36 h of growth.
(TIF)
Figure S3 Transcriptomes profiling of abx1 and covS/R
mutants. (A) Heatmap of the genes (N= 688) with an absolute
log2 ratio .1 in at leat one strain. Deletion (D) for abx1, covS, covR
and the double covRS mutants were compared to the abx1 over-
expression (Oe) mutants obtained by chromosomal (K_) substitu-
tion of the endogenous promoter or with the over-expression
vector (V_; plasmid pTCVVPcyl+_abx1). The WT strain with the
empty vector (NEM_ery) was added to take into account the effect
of the selection pressure necessary for plasmid stability (erythro-
mycin 10 mg/ml). Hierarchical clustering (uncentered; average
linkage) was applied for genes (upper tree) and for arrays/strains
(right tree). Gene expression changes were color-coded (blue = -
down; yellow=up). Main genes clusters are highlighted with red
stars on gene tree and red boxes below the heatmaps. A short
description of the main characteristic of each cluster (number 1 to
8) is given. (B) Highlight of the gene cluster 1 in (A) containing the
genes negatively regulated by CovR conserved in 4 different GBS
serotypes, as defined by independent groups [13,15]. Gene tree is
shown on the left of the heatmap and the corresponding systematic
names and short annotations are on the right. The conserved
CovR-regulated genes are in dark red letters.
(TIF)
Table S1 Transcriptome analyses of abx1 and cov
mutants. (A) Normalized expression ratio for 1905 genes. (B)
Number of genes differentially regulated. (C) Definition of the
CovR regulon in NEM316 and A909 WT starins. (D) List of 229
genes excluded from the analysis.
(XLSX)
Table S2 Bacterial strains and plasmids.
(PDF)
Table S3 Primer sequences.
(PDF)
Table S4 Plasmid construction.
(PDF)
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